Gemigliptin Tartrate(911637-19-9 free base)

Description: Gemigliptin Tartrate (LC15-0444 tartrate) is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties. Target: Proteasome, DPP-4. Smiles: O[C@H]([C@@H](O)C(O)=O)C(O)=O.N[C@H](CN1CC(F)(F)CCC1=O)CC(=O)N1CCc2c(C1)nc(nc2C(F)(F)F)C(F)(F)F. References: Jung E , Kim J , Kim S H , et al. Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo.[J]. European Journal of Pharmacology, 2014, 744:98-102.